Monograph

S01FA04 - Cyclopentolate

Propably not porphyrinogenic

PNP

Rationale

No data on metabolism but probably no significant systemic exposure.

Chemical description

Used in eye drops 10 mg/mL as a mydriatic and cyclopegic. No data on metabolism.

IPNet drug reports

Uneventful use reported in 1 patient with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes S01F / S01FA or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

CYCLOGYL · CYCLOGYL 1% oogdruppels, oplossing · Cyclopentolaathydrochloride · Minims Cyclopentolaathydrochloride 10 mg/ml, oogdruppels, oplossing · Minims Cyclopentolaathydrochloride 5 mg/ml, oogdruppels, oplossing

Belgium

Cyclogyl · Cyclogyl 0.5 % collyre sol. flac. compte-gouttes · Cyclogyl 1 % collyre sol. flac. compte-gouttes · Cyclopentolate Chlorhydrate · Minims Cyclopentolate Chlorhydrate 5 mg/ml collyre sol. récip. unidose

United Kingdom

Minims cyclopentolate hydrochloride · Minims cyclopentolate hydrochloride 0.5% eye drops 0.5ml unit dose · Minims cyclopentolate hydrochloride 1% eye drops 0.5ml unit dose · Mydrilate · Mydrilate 0.5% solution · Mydrilate 1% solution

Denmark